As of Mar 22
| -0.05 / -3.47%|
The 6 analysts offering 12-month price forecasts for Axovant Sciences Ltd have a median target of 5.50, with a high estimate of 8.00 and a low estimate of 2.00. The median estimate represents a +295.68% increase from the last price of 1.39.
The current consensus among 6 polled investment analysts is to Buy stock in Axovant Sciences Ltd. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.